Executive Summary: Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

Chest

Volumn 147, Issue 4, 2015, Pages 883-893

  Criner, Gerard J ^a   Bourbeau, Jean ^b   Diekemper, Rebecca L ^c   Ouellette, Daniel R ^d   Goodridge, Donna ^e   Hernandez, Paul ^f   Curren, Kristen ^g   Balter, Meyer S ^h   Bhutani, Mohit ⁱ   Camp, Pat G ^j   Celli, Bartolome R ^k   Dechman, Gail ^f   Dransfield, Mark T ^l   Fiel, Stanley B ^m   Foreman, Marilyn G ⁿ   Hanania, Nicola A ^o   Ireland, Belinda K ^p   Marchetti, Nathaniel ^a   Marciniuk, Darcy D ^q   Mularski, Richard A ^r   Ornelas, Joseph ^c   Road, Jeremy D ^j   Stickland, Michael K ⁱ   more..

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c American College of Chest Physicians   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g Canadian Lung Association   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m Atlantic Health   (United States)

ⁿ MOREHOUSE SCHOOL OF MEDICINE   (United States)

^o BAYLOR COLLEGE OF MEDICINE   (United States)

^p The EvidenceDoc   (United States)

^q ROYAL UNIVERSITY HOSPITAL   (Canada)

^r CENTER FOR HEALTH RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; DISEASE MANAGEMENT; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONOLOGY; RECURRENT DISEASE; STANDARDS; UNITED STATES;

CANADA; DISEASE MANAGEMENT; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RECURRENCE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84989360042     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1677     Document Type: Article

References (32)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2013. Global Initiative for Chronic Obstructive Lung Disease website. www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf, 2014 Accessed May 15.
2. Brusasco, V, Reducing cholinergic constriction: the major reversible mechanism in COPD. Eur Respir Rev 15:99 (2006), 32–36.
3. Cooper, CB, Airflow obstruction and exercise. Respir Med 103:3 (2009), 325–334.
4. Public Health Agency of Canada. Chronic pulmonary obstructive disease (COPD). Public Health Agency of Canada website. www.phac-aspc.gc.ca/cd-mc/crd-mrc/copd-mpoc-eng.php, 2012 Accessed June 28.
5. Centers for Disease Control and Prevention. National Center for Health Statistics. Deaths: final data for 2009. Natl Vital Stat Rep 60:3 (2012), 1–117.
6. Centers for Disease Control and Prevention; National Center for Health Statistics. National Health Interview Survey Raw Data, 1999-2011. Analysis Performed by the American Lung Association Research and Health Education Division using SPSS and SUDAAN soft ware. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
7. Mannino, DM, Homa, DM, Akinbami, LJ, Ford, ES, Redd, SC, Chronic obstructive pulmonary disease surveillance—United States, 1971-2000. MMWR Surveill Summ 51:6 (2002), 1–16.
8. Centers for Disease Control and Prevention; National Center for Health Statistics. National Hospital Discharge Survey Raw Data, 1999-2010. Analysis Performed by the American Lung Association Research and Health Education Division Using SPSS Soft ware. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
9. C onfronting COPD in America, 2000. Silver Spring, MD: Schulman, Ronca and Bucuvalas, Inc (SRBI); 2000. Funded by GlaxoSmithKline plc.
10. Mittmann, N, Kuramoto, L, Seung, SJ, Haddon, JM, Bradley-Kennedy, C, Fitzgerald, JM, The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med 102:3 (2008), 413–421.
11. Chapman, KR, Bourbeau, J, Rance, L, The burden of COPD in Canada: results from the Confronting COPD survey. Respir Med 97:suppl C (2008), S23–S31.
12. Connors, AF Jr, Dawson, NV, Thomas, C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:4 (1996), 959–967.
13. Seemungal, TA, Donaldson, GC, Paul, EA, Bestall, JC, Jeffries, DJ, Wedzicha, JA, Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:5 (1998), 1418–1422.
14. Miravitlles, M, Murio, C, Guerrero, T, Gisbert, R, DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121:5 (2002), 1449–1455.
15. Miravitlles, M, García-Polo, C, Domenech, A, Villegas, G, Conget, F, de la Roza, C, Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease. Lung 191:5 (2013), 523–530.
16. Wouters, EF, Economic analysis of the Confronting COPD survey: an overview of results. Respir Med 97:suppl C (2003), S3–S14.
17. Celli, BR, MacNee, W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:6 (2004), 932–946.
18. Maltais, F, Celli, B, Casaburi, R, et al. Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med 105:4 (2011), 580–587.
19. Rodriguez-Roisin, R, Toward a consensus definition for COPD exacerbations. Chest 117:5_suppl_2 (2000), 398S–401S.
20. Qaseem, A, Wilt, TJ, Weinberger, SE, et al. American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155:3 (2011), 179–191.
21. Albert, RK, Connett, J, Bailey, WC, et al. COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365:8 (2011), 689–698.
22. Calverley, P, Pauwels, R, Vestbo, J, et al. TRial of Inhaled STeroids ANd long-acting beta2 agonists study group. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 361:9356 (2003), 449–456.
23. Tashkin, DP, Celli, B, Senn, S, et al. UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359:15 (2008), 1543–1554.
24. Guyatt, G, Gutterman, D, Baumann, MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 129:1 (2006), 174–181.
25. Lewis, SZ, Diekemper, R, Ornelas, J, Casey, KR, Methodologies for the development of CHEST guidelines and expert panel reports. Chest 146:1 (2014), 182–192.
26. Bodenheimer, T, Wagner, EH, Grumbach, K, Improving primary care for patients with chronic illness. JAMA 288:14 (2002), 1775–1779.
27. Bodenheimer, T, Wagner, EH, Grumbach, K, Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA 288:15 (2002), 1909–1914.
28. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care London, England. National Clinical Guideline Centre. guidance.nice.org.uk/CG101/Guidance/pdf/English, 2014 Accessed May 15.
29. O'Donnell, DE, Aaron, S, Bourbeau, J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J 14:suppl B (2007), 5B–32B.
30. Craig, P, Dieppe, P, Macintyre, S, Michie, S, Nazareth, I, Petticrew, M, Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ, 337, 2008, a1655.
31. Petticrew, M, When are complex interventions ‘complex'? When are simple interventions ‘simple'?. Eur J Public Health 21:4 (2011), 397–398.
32. Weightman A, Ellis S, Cullum A, Sander L, Turley R. Grading Evidence and Recommendations for Public Health Interventions: Developing and Piloting a Framework. London, England: Health Development Agency; 2005.